SMTL ID : 6mll.1

Crystal structure of KPC-2 with compound 7

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.86 Å

Oligo State

monomer

Ligands

1 x N1G: 1,5-diphenyl-N-(1H-tetrazol-5-yl)-1H-pyrazole-3-carboxamide(Non-covalent)

N1G.1: 13 residues within 4Å: Chain A: S.66, P.100, W.101, S.126, N.128, L.163, N.166, T.212, K.230, T.231, G.232, T.233, C.234 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.100, A:W.101, A:L.163 Hydrogen bonds: A:S.66, A:S.66, A:S.126, A:K.230, A:T.233, A:T.233 Water bridges: A:N.166, A:N.166

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 4 residues within 4Å: Chain A: Q.201, K.208, A.226, W.247 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.201, A:K.208, A:K.208

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Torelli, N.J. et al., Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery. Acs Infect Dis. (2019)

Release Date

2019-04-17

Peptides

Carbapenem-hydrolyzing beta-lactamase KPC: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carbapenem-hydrolyzing beta-lactamase KPC

Related Entries With Identical Sequence